Drug composition matters: the influence of carrier concentration on the radiochemical purity, hydroxyapatite affinity and in-vivo bone accumulation of the therapeutic radiopharmaceutical (188)Rhenium-HEDP

R. Lange; J.M.H. de Klerk; H.J. Bloemendal; R.M. Ramakers; F.J. Beekman; M.M.L. van der Westerlaken; N.H. Hendrikse; R. ter Heine

doi:https://doi.org/10.1016/j.nucmedbio.2015.01.007

Drug composition matters: the influence of carrier concentration on the radiochemical purity, hydroxyapatite affinity and in-vivo bone accumulation of the therapeutic radiopharmaceutical (188)Rhenium-HEDP

R. Lange, J.M.H. de Klerk, H.J. Bloemendal, R.M. Ramakers, F.J. Beekman, M.M.L. van der Westerlaken, N.H. Hendrikse, R. ter Heine

Clinical pharmacology and pharmacy (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

9 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	465-469
Journal	Nuclear medicine and biology
Volume	42
Issue number	5
DOIs	https://doi.org/10.1016/j.nucmedbio.2015.01.007
Publication status	Published - 2015

Access to Document

https://doi.org/10.1016/j.nucmedbio.2015.01.007

Cite this

Lange, R., de Klerk, J. M. H., Bloemendal, H. J., Ramakers, R. M., Beekman, F. J., van der Westerlaken, M. M. L., Hendrikse, N. H., & ter Heine, R. (2015). Drug composition matters: the influence of carrier concentration on the radiochemical purity, hydroxyapatite affinity and in-vivo bone accumulation of the therapeutic radiopharmaceutical (188)Rhenium-HEDP. Nuclear medicine and biology, 42(5), 465-469. https://doi.org/10.1016/j.nucmedbio.2015.01.007

@article{630ef1ce31604264b987709042d7cc7d,

title = "Drug composition matters: the influence of carrier concentration on the radiochemical purity, hydroxyapatite affinity and in-vivo bone accumulation of the therapeutic radiopharmaceutical (188)Rhenium-HEDP",

author = "R. Lange and {de Klerk}, J.M.H. and H.J. Bloemendal and R.M. Ramakers and F.J. Beekman and {van der Westerlaken}, M.M.L. and N.H. Hendrikse and {ter Heine}, R.",

year = "2015",

doi = "https://doi.org/10.1016/j.nucmedbio.2015.01.007",

language = "Undefined/Unknown",

volume = "42",

pages = "465--469",

journal = "Nuclear medicine and biology",

issn = "0969-8051",

publisher = "Elsevier Inc.",

number = "5",

}

Lange, R, de Klerk, JMH, Bloemendal, HJ, Ramakers, RM, Beekman, FJ, van der Westerlaken, MML, Hendrikse, NH & ter Heine, R 2015, 'Drug composition matters: the influence of carrier concentration on the radiochemical purity, hydroxyapatite affinity and in-vivo bone accumulation of the therapeutic radiopharmaceutical (188)Rhenium-HEDP', Nuclear medicine and biology, vol. 42, no. 5, pp. 465-469. https://doi.org/10.1016/j.nucmedbio.2015.01.007

Drug composition matters: the influence of carrier concentration on the radiochemical purity, hydroxyapatite affinity and in-vivo bone accumulation of the therapeutic radiopharmaceutical (188)Rhenium-HEDP. / Lange, R.; de Klerk, J.M.H.; Bloemendal, H.J. et al.
In: Nuclear medicine and biology, Vol. 42, No. 5, 2015, p. 465-469.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Drug composition matters: the influence of carrier concentration on the radiochemical purity, hydroxyapatite affinity and in-vivo bone accumulation of the therapeutic radiopharmaceutical (188)Rhenium-HEDP

AU - Lange, R.

AU - de Klerk, J.M.H.

AU - Bloemendal, H.J.

AU - Ramakers, R.M.

AU - Beekman, F.J.

AU - van der Westerlaken, M.M.L.

AU - Hendrikse, N.H.

AU - ter Heine, R.

PY - 2015

Y1 - 2015

U2 - https://doi.org/10.1016/j.nucmedbio.2015.01.007

DO - https://doi.org/10.1016/j.nucmedbio.2015.01.007

M3 - Article

C2 - 25662844

SN - 0969-8051

VL - 42

SP - 465

EP - 469

JO - Nuclear medicine and biology

JF - Nuclear medicine and biology

IS - 5

ER -

Lange R, de Klerk JMH, Bloemendal HJ, Ramakers RM, Beekman FJ, van der Westerlaken MML et al. Drug composition matters: the influence of carrier concentration on the radiochemical purity, hydroxyapatite affinity and in-vivo bone accumulation of the therapeutic radiopharmaceutical (188)Rhenium-HEDP. Nuclear medicine and biology. 2015;42(5):465-469. doi: https://doi.org/10.1016/j.nucmedbio.2015.01.007